Edgar Filing: MAXIM INTEGRATED PRODUCTS INC

10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)



[X]	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the quarterly period ended December 26, 2015



[ ]	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the transition period from ________ to ________.

Commission file number 1-34192

MAXIM INTEGRATED PRODUCTS, INC.

(Exact name of Registrant as Specified in its Charter)



Delaware (State or Other Jurisdiction of Incorporation or Organization)		94-2896096 (I.R.S. Employer I. D. No.)

160 Rio Robles

San Jose, California 95134

(Address of Principal Executive Offices including Zip Code)

(408) 601-1000

(Registrant’s Telephone Number, Including Area Code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file reports), and (2) has been subject to such filing requirements for the past 90 days. YES [x] NO [ ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). YES [x] NO [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller” reporting company in Rule 12b-2 of the Exchange Act. (Check one):



Large accelerated filer [x]	Accelerated filer [ ]	Non-accelerated filer [ ] (Do not check if a smaller reporting company)	Smaller reporting company [ ]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). (Check one):

YES [ ] NO [x]

As of January 15, 2016 there were 286,398,344 shares of Common Stock, par value $.001 per share, of the registrant outstanding.

MAXIM INTEGRATED PRODUCTS, INC.

INDEX



PART I - FINANCIAL INFORMATION		Page

Item 1. Financial Statements (Unaudited)		3

Condensed Consolidated Balance Sheets as of December 26, 2015 and June 27, 2015		3

Condensed Consolidated Statements of Income for the Three and Six Months Ended December 26, 2015 and December 27, 2014		4

Condensed Consolidated Statements of Comprehensive Income for the Three and Six Months Ended December 26, 2015 and December 27, 2014		5

Condensed Consolidated Statements of Cash Flows for the Six Months Ended December 26, 2015 and December 27, 2014		6

Notes to Condensed Consolidated Financial Statements		7

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations		25

Item 3. Quantitative and Qualitative Disclosures About Market Risk		32

Item 4. Controls and Procedures		32

PART II - OTHER INFORMATION		34

Item 1. Legal Proceedings		34

Item 1A. Risk Factors		34

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds		34

Item 3. Defaults Upon Senior Securities		34

Item 4. Mine Safety Disclosures		34

Item 5. Other Information		34

Item 6. Exhibits		35

SIGNATURES		36

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)

MAXIM INTEGRATED PRODUCTS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)



	December 26, 2015			June 27, 2015
	(in thousands)
ASSETS
Current assets:
Cash and cash equivalents	$	1,648,518		$	1,550,965
Short-term investments	124,955			75,154
Total cash, cash equivalents and short-term investments	1,773,473			1,626,119
Accounts receivable, net	231,180			278,844
Inventories	274,741			288,474
Deferred tax assets	—			77,306
Other current assets	47,235			49,838
Total current assets	2,326,629			2,320,581
Property, plant and equipment, net	770,548			1,090,739
Intangible assets, net	202,877			261,652
Goodwill	490,648			511,647
Other assets	64,105			35,557
Assets held for sale	82,674			8,208
TOTAL ASSETS	$	3,937,481		$	4,228,384

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	74,145		$	88,322
Income taxes payable	32,528			34,779
Accrued salary and related expenses	129,208			181,360
Accrued expenses	47,303			48,389
Deferred revenue on shipments to distributors	32,067			30,327
Total current liabilities	315,251			383,177
Long-term debt	1,000,000			1,000,000
Income taxes payable	419,881			410,378
Deferred tax liabilities	651			90,588
Other liabilities	52,874			54,221
Total liabilities	1,788,657			1,938,364

Commitments and contingencies (Note 11)

Stockholders’ equity:
Common stock and capital in excess of par value	63,014			28,142
Retained earnings	2,103,339			2,279,112
Accumulated other comprehensive loss	(17,529		)	(17,234		)
Total stockholders’ equity	2,148,824			2,290,020
TOTAL LIABILITIES & STOCKHOLDERS’ EQUITY	$	3,937,481		$	4,228,384

See accompanying Notes to Condensed Consolidated Financial Statements.

MAXIM INTEGRATED PRODUCTS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(Unaudited)



	Three Months Ended						Six Months Ended
	December 26, 2015			December 27, 2014			December 26, 2015			December 27, 2014
	(in thousands, except per share data)

Net revenues	$	510,831		$	566,809		$	1,073,341		$	1,147,084
Cost of goods sold	218,662			252,732			494,821			494,186
Gross margin	292,169			314,077			578,520			652,898
Operating expenses:
Research and development	113,100			135,945			234,492			276,307
Selling, general and administrative	73,643			79,778			145,638			159,767
Intangible asset amortization	3,538			4,155			7,129			8,482
Impairment of long-lived assets	1,950			50,745			159,647			60,971
Impairment of goodwill and intangible assets	—			93,010			—			93,010
Severance and restructuring expenses	10,652			13,635			17,778			15,020
Other operating expenses (income), net	(247		)	885			68			2,459
Total operating expenses	202,636			378,153			564,752			616,016
Operating income (loss)	89,533			(64,076		)	13,768			36,882
Interest and other income (expense), net	(9,593		)	(7,599		)	(15,995		)	(14,076		)
Income (loss) before provision for income taxes	79,940			(71,675		)	(2,227		)	22,806
Income tax provision (benefit)	12,471			359			2,447			(5,140		)
Net income (loss)	$	67,469		$	(72,034	)	$	(4,674	)	$	27,946

Earnings (loss) per share:
Basic	$	0.24		$	(0.25	)	$	(0.02	)	$	0.10
Diluted	$	0.23		$	(0.25	)	$	(0.02	)	$	0.10

Shares used in the calculation of earnings (loss) per share:
Basic	285,526			282,992			285,057			283,539
Diluted	290,521			282,992			285,057			288,876

Dividends declared and paid per share	$	0.30		$	0.28		$	0.60		$	0.56

See accompanying Notes to Condensed Consolidated Financial Statements.

MAXIM INTEGRATED PRODUCTS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Unaudited)



	Three Months Ended						Six Months Ended
	December 26, 2015			December 27, 2014			December 26, 2015			December 27, 2014
	(in thousands)
Net income (loss)	$	67,469		$	(72,034	)	$	(4,674	)	$	27,946
Other comprehensive income (loss), net of tax:
Change in net unrealized gains and losses on available-for-sale securities, net of tax benefit (expense) of $0	(359		)	(83		)	(283		)	(108		)
Change in net unrealized gains and losses on cash flow hedges, net of tax benefit (expense) of $(22), $(89), $170 and $381, respectively	258			472			(356		)	(1,103		)
Change in net unrealized gains and losses on post-retirement benefits, net of tax benefit (expense) of $(81), $(121), $(161) and $(242), respectively	172			238			344			477
Tax effect of the unrealized exchange gains and losses on long-term intercompany receivables	—			(92		)	—			(632		)
Other comprehensive income (loss), net	71			535			(295		)	(1,366		)
Total comprehensive income (loss)	$	67,540		$	(71,499	)	$	(4,969	)	$	26,580

See accompanying Notes to Condensed Consolidated Financial Statements.

MAXIM INTEGRATED PRODUCTS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)



	Six Months Ended
	December 26, 2015			December 27, 2014
	(in thousands)
Cash flows from operating activities:
Net income (loss)	$	(4,674	)	$	27,946
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Stock-based compensation	35,382			43,196
Depreciation and amortization	151,135			135,318
Deferred taxes	(34,295		)	(24,642		)
Loss (gain) from sale of property, plant and equipment	(5,863		)	2,088
Tax benefit related to stock-based compensation	3,173			1,381
Impairment of long-lived assets	159,647			60,971
Impairment of goodwill and intangible assets	—			93,010
Excess tax benefit from stock-based compensation	(6,169		)	(4,180		)
Changes in assets and liabilities:
Accounts receivable	47,664			37,322
Inventories	13,644			(17,136		)
Other current assets	3,878			(23,965		)
Accounts payable	(17,435		)	(7,552		)
Income taxes payable	7,252			546
Deferred revenue on shipments to distributors	1,740			1,369
All other accrued liabilities	(55,251		)	(35,820		)
Net cash provided by (used in) operating activities	299,828			289,852
Cash flows from investing activities:
Purchase of property, plant and equipment	(29,351		)	(50,271		)
Proceeds from sale of property, plant and equipment	50,315			24,679
Purchases of available-for-sale securities	(50,087		)	(25,142		)
Purchases of privately-held companies' securities	(7,008		)	—
Other investing activities	2,380			—
Net cash provided by (used in) investing activities	(33,751		)	(50,734		)
Cash flows from financing activities:
Excess tax benefit from stock-based compensation	6,169			4,180
Repayment of notes payable	—			(437		)
Net issuance of restricted stock units	(12,544		)	(14,860		)
Proceeds from stock options exercised	57,447			18,027
Issuance of common stock under employee stock purchase program	14,350			18,653
Repurchase of common stock	(62,847		)	(122,351		)
Dividends paid	(171,099		)	(158,932		)
Net cash provided by (used in) financing activities	(168,524		)	(255,720		)
Net increase (decrease) in cash and cash equivalents	97,553			(16,602		)
Cash and cash equivalents:
Beginning of period	1,550,965			1,322,472
End of period	$	1,648,518		$	1,305,870
Supplemental disclosures of cash flow information:
Cash paid net during the period for income taxes	$	24,520		$	21,283
Cash paid for interest	$	14,693		$	14,712
Noncash financing and investing activities:
Accounts payable related to property, plant and equipment purchases	$	8,179		$	2,476

See accompanying Notes to Condensed Consolidated Financial Statements.

MAXIM INTEGRATED PRODUCTS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

NOTE 1: BASIS OF PRESENTATION

The accompanying unaudited condensed consolidated financial statements of Maxim Integrated Products, Inc. and all of its majority-owned subsidiaries (collectively, the “Company” or “Maxim Integrated”) included herein have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with generally accepted accounting principles of the United States of America (“GAAP”) have been condensed or omitted pursuant to applicable rules and regulations. In the opinion of management, all adjustments of a normal recurring nature which were considered necessary for fair presentation have been included. The year-end condensed consolidated balance sheet data were derived from audited consolidated financial statements but do not include all disclosures required by GAAP. The results of operations for the six months ended December 26, 2015 are not necessarily indicative of the results to be expected for the entire year. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in the Annual Report on Form 10-K for the fiscal year ended June 27, 2015.

The Company has a 52-to-53-week fiscal year that ends on the last Saturday in June. Accordingly, every fifth or sixth fiscal year will be a 53-week fiscal year. Fiscal year 2015 was a 52-week fiscal years and fiscal year 2016 will also be a 52-week fiscal year.

NOTE 2: RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

(i) New Accounting Updates Recently Adopted

In April 2014, the FASB issued ASU No. 2014-08, Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity. ASU No. 2014-08 redefines discontinued operations as disposals representing a strategic shift in operations and having a major effect on the organization’s operations and financial results. The Company early adopted this accounting standard update in the fourth quarter of fiscal year 2015.

In November 2015, the FASB issued ASU No. 2015-17, Balance Sheet Classification of Deferred Taxes, which eliminates the current requirement to present deferred tax assets and liabilities as current and noncurrent in a classified balance sheet. Instead, entities will be required to classify all deferred tax assets and liabilities as noncurrent. The Company early adopted this accounting standard update, on a prospective basis, at the beginning of the second quarter of fiscal year 2016. All deferred tax assets and liabilities as of December 26, 2015, have been classified as noncurrent in the accompanying Condensed Consolidated Balance Sheets and the notes thereto. The adoption at the beginning of the quarter resulted in a $50.6 million decrease in current deferred tax assets, a $40.7 million increase in other assets and a $9.9 million decrease to non-current deferred tax liabilities. No prior periods were retrospectively adjusted.

(ii) Recent Accounting Updates Not Yet Effective

In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606). ASU No. 2014-09 uses a five-step model to determine revenue recognition in contracts with customers. The Company is currently evaluating the potential impact of this standard on its financial statements. ASU No. 2014-09 is effective for the Company in the first quarter of fiscal year 2019 using either of two methods: (i) retrospective to each prior reporting period presented with the option to elect certain practical expedients as defined within ASU No. 2014-09; or (ii) retrospective with the cumulative effect of initially applying ASU No. 2014-09 recognized at the date of initial application and providing certain additional disclosures as defined per ASU No. 2014-09. Early adoption in the first quarter of fiscal year 2018 is permitted.

In April 2015, the FASB issued ASU No. 2015-03, Interest - Imputation of Interest. ASU No. 2015-03 changes the presentation of debt issuance costs in financial statements. Under the new guidance, an entity presents such costs in the balance sheet as a direct deduction from the related debt liability rather than as an asset. Amortization of the costs is reported as interest expense. This guidance is effective beginning in the first quarter of fiscal year 2017 and early adoption is permitted in an interim period with any adjustments reflected as of the beginning of the fiscal year that includes that interim period. The company does not believe the guidance will result in a material impact to its consolidated financial statements.

In July 2015, the FASB issued ASU No. 2015-11, Inventory (Topic 330): Simplifying the Measurement of Inventory, which changes the measurement principle for inventory from the lower of cost or market to the lower of cost and net realizable value. ASU No. 2015-11 defines net realizable value as estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. The new guidance must be applied on a prospective basis and is effective for

the Company in the first quarter of fiscal year 2017, with early adoption permitted. The Company does not believe the implementation of this standard will result in a material impact to its consolidated financial statements.

In January 2016, the FASB issued ASU 2016-01, Recognition and Measurement of Financial Assets and Financial Liabilities, which provides guidance for the recognition, measurement, presentation, and disclosure of financial assets and liabilities. This ASU will be effective for the Company beginning in the first quarter of fiscal year 2019. The Company is evaluating the effects of the adoption of this ASU to its financial statements.

NOTE 3: BALANCE SHEET COMPONENTS

Accounts receivable, net consists of:



	December 26, 2015			June 27, 2015
Accounts Receivable:	(in thousands)
Accounts receivable	$	247,468		$	297,130
Returns and allowances	(16,288		)	(18,286		)
	$	231,180		$	278,844

Inventories consist of:



	December 26, 2015		June 27, 2015
Inventories:	(in thousands)
Raw materials	$	12,611	$	12,932
Work-in-process	178,650		199,716
Finished goods	83,480		75,826
	$	274,741	$	288,474

Property, plant and equipment, net consists of:



	December 26, 2015			June 27, 2015
Property, plant and equipment:	(in thousands)
Land	$	24,631		$	45,040
Buildings and building improvements	275,823			338,394
Machinery and equipment	1,431,786			1,970,819
	1,732,240			2,354,253
Less: accumulated depreciation and amortization	(961,692		)	(1,263,514		)
	$	770,548		$	1,090,739

Other assets consist of:



	December 26, 2015		June 27, 2015
Other assets:	(in thousands)
Licenses	9,002		8,665
Deferred taxes	23,120		1,447
Other	31,983		25,445
	$	64,105	$	35,557

Assets held for sale consist of:

As of December 26, 2015, assets held for sale primarily consist of land, building and equipment for the Company's wafer manufacturing facility in San Antonio, classified as held for sale during the first quarter of fiscal 2016. In addition, assets held for sale consist of goodwill, intangible assets and equipment of certain business units classified as held for sale during the second quarter of fiscal 2016.

As of June 27, 2015, assets held for sale consisted of land and buildings related to the Company's manufacturing facility in Batangas, the Philippines. This facility was sold in the second quarter of fiscal 2016.



	December 26, 2015		June 27, 2015
Assets held for sale:	(in thousands)
Property, plant and equipment, less accumulated depreciation	$	41,402	$	8,208
Goodwill	20,999		—
Identifiable intangible assets, less accumulated amortization	20,273		—
	$	82,674	$	8,208

Accrued salary and related expenses consist of:



	December 26, 2015		June 27, 2015
Accrued salary and related expenses:	(in thousands)
Accrued vacation	$	35,033	$	36,906
Accrued bonus	41,691		86,506
Accrued severance and post-employment benefits	19,933		25,136
Accrued salaries	15,511		16,572
Accrued fringe	6,106		6,007
Other	10,934		10,233
	129,208		$	181,360

Accrued expenses consist of:



	December 26, 2015		June 27, 2015
Accrued expenses:	(in thousands)
Accrued self-insurance	$	9,040	$	10,882
Accrued contract settlement	10,691		10,691
Accrued interest	6,660		6,660
Other	20,912		20,156
	$	47,303	$	48,389

NOTE 4: FAIR VALUE MEASUREMENTS

The FASB established a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. This hierarchy requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Three levels of inputs that may be used to measure fair value are as follows:

Level 1 - Quoted (unadjusted) prices in active markets for identical assets or liabilities.

The Company’s Level 1 assets consist of money market funds.

Level 2 - Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability.

The Company’s Level 2 assets and liabilities consist of U.S. treasury bills and foreign currency forward contracts that are valued using quoted market prices or are determined using a yield curve model based on current market rates. As a result, the Company has classified these investments as Level 2 in the fair value hierarchy.

Level 3 - Unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.

The Company did not hold any Level 3 assets or liabilities as of December 26, 2015 and June 27, 2015.

Assets and liabilities measured at fair value on a recurring basis were as follows:



	As of December 26, 2015								As of June 27, 2015
	Fair Value Measurements Using						Total Balance		Fair Value Measurements Using						Total Balance
	Level 1		Level 2		Level 3		Total Balance		Level 1		Level 2		Level 3		Total Balance
	(in thousands)
Assets
Money market funds (1)	$	1,230,289	$	—	$	—	$	1,230,289	$	1,156,239	$	—	$	—	$	1,156,239
U.S. treasury bills (2)	—		124,955		—		124,955		—		75,154		—		75,154
Foreign currency forward contracts (3)	—		226		—		226		—		679		—		679
Total Assets	$	1,230,289	$	125,181	$	—	$	1,355,470	$	1,156,239	$	75,833	$	—	$	1,232,072

Liabilities
Foreign currency forward contracts (4)	$	—	$	674	$	—	$	674	$	—	$	613	$	—	$	613
Total Liabilities	$	—	$	674	$	—	$	674	$	—	$	613	$	—	$	613

(1) Included in Cash and cash equivalents in the accompanying Condensed Consolidated Balance Sheets.

(2) Included in Short-term investments in the accompanying Condensed Consolidated Balance Sheets.

(3) Included in Other current assets in the accompanying Condensed Consolidated Balance Sheets.

(4) Included in Accrued expenses in the accompanying Condensed Consolidated Balance Sheets.

The tables below present reconciliations for liabilities measured and recorded at fair value on a recurring basis using significant unobservable inputs (Level 3) for the six months ended December 26, 2015 and December 27, 2014:



Fair Value Measured and Recorded Using Significant Unobservable Inputs (Level 3)

	December 26, 2015		December 27, 2014
Contingent Consideration	(in thousands)
Beginning balance	$	—	$	3,215
Total gains or losses (realized and unrealized):
Included in earnings	—		384
Payments	—		(3,599		)
Ending balance	$	—	$	—

Changes in unrealized losses (gains) included in earnings related to liabilities still held as of period end	$	—	$	—

During the six months ended December 26, 2015 and December 27, 2014, there were no transfers in or out of Level 3 from other levels in the fair value hierarchy.

There were no assets or liabilities measured at fair value on a non-recurring basis as of December 26, 2015 and June 27, 2015 other than impairments of Long-Lived assets. For details, please refer to Note 14: “Impairment of long-lived assets”.

NOTE 5: FINANCIAL INSTRUMENTS

Short-term investments

Fair values were as follows:



	December 26, 2015								June 27, 2015
	Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss		Estimated Fair Value		Amortized Cost		Gross Unrealized Gain		Gross Unrealized Loss		Estimated Fair Value
	(in thousands)
Available-for-sale investments
U.S. Treasury notes	$	125,105	$	—	$	150	$	124,955	$	75,022	$	132	$	—	$	75,154
Total available-for-sale investments	$	125,105	$	—	$	150	$	124,955	$	75,022	$	132	$	—	$	75,154

In the six months ended December 26, 2015 and the year ended June 27, 2015, the Company did not recognize any impairment charges on short-term investments. The U.S. Treasury notes have maturity dates between May 15, 2016 and December 15, 2017.

Derivative instruments and hedging activities

The Company incurs expenditures denominated in non-U.S. currencies, primarily the Philippine Peso and the Thai Baht associated with the Company's manufacturing activities in the Philippines and Thailand, respectively, and European Union Euro, South Korean Won, and Japanese Yen expenditures for sales offices and research and development activities undertaken outside of the U.S.

The Company has established a program that primarily utilizes foreign currency forward contracts to offset the risks associated with the effects of certain foreign currency exposures. The Company does not use these foreign currency forward contracts for trading purposes.

Derivatives designated as cash flow hedging instruments

The Company designates certain forward contracts as hedging instruments pursuant to Accounting Standards Codification (“ASC”) No. 815-Derivatives and Hedging (“ASC 815”). As of December 26, 2015 and June 27, 2015, the notional amounts of the forward contracts the Company held to purchase international currencies were $44.0 million and $54.2 million, respectively, and the notional amounts of forward contracts the Company held to sell international currencies were $2.7 million and $3.7 million, respectively.

Derivatives not designated as hedging instruments

As of December 26, 2015 and June 27, 2015, the notional amounts of the forward contracts the Company held to purchase international currencies were $23.8 million and $31.1 million, respectively, and the notional amounts of forward contracts the Company held to sell international currencies were $24.1 million and $28.2 million, respectively. The fair values of our outstanding foreign currency forward contracts and amounts included in the Condensed Consolidated Statement of Income were not material for the six months ended December 26, 2015 and the year ended June 27, 2015.

Long-term debt

The following table summarizes the Company’s long-term debt:



	December 26, 2015		June 27, 2015
	(in thousands)
2.5% fixed rate notes due November 2018	$	500,000	$	500,000
3.375% fixed rate notes due March 2023	500,000		500,000
Notes denominated in Euro
Term fixed rate notes (2.0%) due on September 30, 2015	—		1,024
Total	1,000,000		1,001,024
Less: Current portion (included in “Accrued expenses”)	—		(1,024		)
Total long-term debt	$	1,000,000	$	1,000,000

On November 21, 2013, the Company completed a public offering of $500 million aggregate principal amount of the Company’s 2.5% coupon senior unsecured and unsubordinated notes due in November 2018 (“2018 Notes”), with an effective interest rate of 2.6%. Interest on the 2018 Notes is payable semi-annually in arrears on May 15 and November 15 of each year, commencing on May 15, 2014. The net proceeds of this offering were approximately $494.5 million, after issuing at a discount and deducting paid expenses.

On March 18, 2013, the Company completed a public offering of $500 million aggregate principal amount of the Company’s 3.375% senior unsecured and unsubordinated notes due in March 2023 (“2023 Notes”), with an effective interest rate of 3.5%. Interest on the 2023 Notes is payable semi-annually in arrears on March 15 and September 15 of each year. The net proceeds of this offering were approximately $490.0 million, after issuing at a discount and deducting paid expenses.

The Company accounts for all the notes above based on their amortized cost. The discount and expenses are being amortized to Interest and other income (expense), net in the Condensed Consolidated Statements of Income over the life of the notes. The interest expense is recorded in Interest and other income (expense), net in the Condensed Consolidated Statements of Income. Amortized discount and expenses, as well as interest expense associated with the notes was $8.2 million and $8.0 million during the three months ended December 26, 2015 and December 27, 2014, respectively.

The estimated fair value of the Company’s debt was approximately $995 million as of December 26, 2015. The estimated fair value of the debt is based primarily on observable market inputs and is a Level 2 measurement.

Credit Facility

The Company has access to a $350 million senior unsecured revolving credit facility with certain institutional lenders that expires on June 27, 2019. The facility fee is at a rate per annum that varies based on the Company’s index debt rating and any advances under the credit agreement will accrue interest at a base rate plus a margin based on the Company’s index debt rating. The credit agreement requires the Company to comply with certain covenants, including a requirement that the Company maintain a ratio of debt to EBITDA (earnings before interest, taxes, depreciation, and amortization) of not more than 3 to 1 and a minimum interest coverage ratio (EBITDA divided by interest expense) greater than 3.5 to 1. As of December 26, 2015, the Company had not borrowed any amounts from this credit facility and was in compliance with all debt covenants.

Other Financial Instruments

For the balance of the Company’s financial instruments, cash equivalents, accounts receivable, accounts payable and other accrued liabilities, the carrying amounts approximate fair value due to their short maturities.

NOTE 6: STOCK-BASED COMPENSATION

At December 26, 2015, the Company had one stock incentive plan, the Company's Amended and Restated 1996 Stock Incentive Plan (the “1996 Plan”) and one employee stock purchase plan, the 2008 Employee Stock Purchase Plan (the “2008 ESP Plan”). The 1996 Plan was adopted by the Board of Directors to provide the grant of stock options, restricted stock units (“RSUs”), and restricted stock and performance shares, including market stock units (“MSUs”) to employees, directors, and consultants.

Pursuant to the 1996 Plan, the exercise price for all stock options is determined to be the fair market value of the underlying shares on the date of grant. Options typically vest ratably over a four-year period measured from the date of grant. Stock options expire no later than ten years after the date of grant, subject to earlier termination upon an optionee's cessation of employment or service.

RSUs granted to employees typically vest ratably over a four-year period and are converted into shares of the Company's common stock upon vesting, subject to the employee's continued service to the Company over that period.

MSUs granted to employees have a four-year measurement period and are converted into shares of the Company's common stock at the end of the measurement period and upon vesting, subject to the employee's continued service to the Company over that period. The number of shares that are released at the end of the performance period can range from zero to a maximum cap of two hundred percent (200%) of target depending on the Company's performance in comparison to the Semiconductor Exchange Traded Fund index, (the “XSD”). The performance metrics of this program are based on relative performance of the Company’s stock price as compared to the XSD during the measurement period.

The following tables show total stock-based compensation expense by type of award, and the resulting tax effect, included in the Condensed Consolidated Statements of Income for the three and six months ended December 26, 2015 and December 27, 2014, respectively:



	Three Months Ended
	December 26, 2015								December 27, 2014
	Stock Options		Restricted Stock Units		Employee Stock Purchase Plan		Total		Stock Options		Restricted Stock Units		Employee Stock Purchase Plan		Total
	(in thousands)
Cost of goods sold	$	279	$	1,970	$	621	$	2,870	$	362	$	2,076	$	550	$	2,988
Research and development	843		7,210		1,085		9,138		1,587		8,415		1,219		11,221
Selling, general and administrative	802		5,138		471		6,411		1,029		5,038		500		6,567
Pre-tax stock-based compensation expense	$	1,924	$	14,318	$	2,177	$	18,419	$	2,978	$	15,529	$	2,269	$	20,776
Less: income tax effect							3,295								3,365
Net stock-based compensation expense							$	15,124							$	17,411



	Six Months Ended
	December 26, 2015								December 27, 2014
	Stock Options		Restricted Stock Units		Employee Stock Purchase Plan		Total		Stock Options		Restricted Stock Units		Employee Stock Purchase Plan		Total
	(in thousands)
Cost of goods sold	$	614	3,958		1,180		$	5,752	$	701	$	4,050	$	1,074	$	5,825
Research and development	1,713		13,084		2,382		17,179		3,734		17,247		2,562		23,543
Selling, general and administrative	1,620		9,764		1,067		12,451		2,458		10,262		1,108		13,828
Pre-tax stock-based compensation expense	$	3,947	$	26,806	$	4,629	$	35,382	$	6,893	$	31,559	$	4,744	$	43,196
Less: income tax effect							6,057								6,637
Net stock-based compensation expense							$	29,325							$	36,559

The expenses included in the Condensed Consolidated Statements of Income related to RSUs include expenses related to MSUs of $0.8 million and $0.6 million for the three months ended December 26, 2015 and December 27, 2014, respectively and $1.3 million and $0.9 million for the six months ended December 26, 2015 and December 27, 2014, respectively.

Stock Options

The fair value of options granted to employees under the 1996 Plan is estimated on the date of grant using the Black-Scholes option valuation model.

Expected volatilities are based on the historical volatilities from the Company’s traded common stock over a period equal to the expected term. The Company is utilizing the simplified method to estimate expected holding periods. The risk-free interest rate is based on the U.S. Treasury yield. The Company determines the dividend yield by dividing the annualized dividends per share by the prior quarter’s average stock price. The Company also estimates forfeitures at the time of grant and makes revisions to forfeitures on a quarterly basis.

The fair value of options granted to employees has been estimated using the following weighted-average assumptions:



	Stock Options
	Three Months Ended				Six Months Ended
	December 26, 2015		December 27, 2014		December 26, 2015		December 27, 2014
Expected holding period (in years)	0.0		5.0		0.0		4.8
Risk-free interest rate	—	%	1.7	%	—	%	1.6	%
Expected stock price volatility	—	%	26.8	%	—	%	26.7	%
Dividend yield	—	%	3.5	%	—	%	3.2	%

There were no stock options granted in the three and six months ended December 26, 2015. The weighted-average fair value of stock options granted was $4.79 and $5.56 per share for the three and six months ended December 27, 2014, respectively.

The following table summarizes outstanding, exercisable and vested and expected to vest stock options as of December 26, 2015 and their activity for the six months ended December 26, 2015:



	Number of Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (in Years)	Aggregate Intrinsic Value (1)
Balance at June 27, 2015	10,173,016		$	25.83
Options Granted	—		—
Options Exercised	(2,198,354	)	26.25
Options Cancelled	(689,633	)	33.47
Balance at December 26, 2015	7,285,029		$	24.98	3.3	$	98,360,731
Exercisable, December 26, 2015	3,547,516		$	21.89	2.2	$	58,325,173
Vested and expected to vest, December 26, 2015	7,092,264		$	24.86	3.2	$	95,523,711



(1)	Aggregate intrinsic value represents the difference between the exercise price and the closing price per share of the Company’s common stock on December 24, 2015, the last business day preceding the fiscal quarter-end, multiplied by the number of options outstanding, exercisable or vested and expected to vest as of December 26, 2015.

As of December 26, 2015, there was $11.5 million of total unrecognized stock compensation cost related to 3.7 million unvested stock options, which is expected to be recognized over a weighted average period of approximately 2.2 years.

Restricted Stock Units and Other Awards

The fair value of RSUs and other awards under the Company’s 1996 Plan is estimated using the value of the Company’s common stock on the date of grant, reduced by the present value of dividends expected to be paid on the Company’s common stock prior to vesting. The Company also estimates forfeitures at the time of grant and makes revisions to forfeitures on a quarterly basis.

The weighted-average fair value of RSUs and other awards granted was $36.14 and $27.24 per share for the three months ended December 26, 2015 and December 27, 2014, respectively.

The weighted-average fair value of RSUs and other awards granted was $28.70 and $27.18 per share for the six months ended December 26, 2015 and December 27, 2014, respectively.

The following table summarizes the outstanding and expected to vest RSUs and other awards as of December 26, 2015 and their activity during the six months ended December 26, 2015:



	Number of Shares		Weighted Average Remaining Contractual Term (in Years)	Aggregate Intrinsic Value (1)
Balance at June 27, 2015	7,129,985
Restricted stock units and other awards granted	2,303,680
Restricted stock units and other awards released	(1,005,291	)
Restricted stock units and other awards cancelled	(754,853	)
Balance at December 26, 2015	7,673,521		2.9	$	293,743,258
Outstanding and expected to vest, December 26, 2015	6,546,450		2.8	$	248,084,773



(1)	Aggregate intrinsic value for RSUs and other awards represents the closing price per share of the Company’s common stock on December 24, 2015, the last business day preceding the fiscal quarter-end, multiplied by the number of RSUs outstanding or expected to vest as of December 26, 2015.

The Company withheld shares totaling $7.7 million and $12.5 million in value as a result of employee withholding taxes based on the value of the RSUs on their vesting date for the three and six months ended December 26, 2015, respectively. The total payments for the employees’ tax obligations to the taxing authorities are reflected as financing activities within the Condensed Consolidated Statements of Cash Flows.

As of December 26, 2015, there was $152.9 million of unrecognized compensation expense related to 7.7 million unvested RSUs and other awards, which is expected to be recognized over a weighted average period of approximately 2.9 years.

Market Stock Units

The Company granted MSUs to senior members of management in September 2014 and September 2015. The grant of MSUs was in lieu of granting stock options. MSUs are valued based on the relative performance of the Company’s stock price as compared to the XSD. The fair value of MSUs is estimated using a Monte Carlo simulation model on the date of grant. The Company also estimates forfeitures at the time of grant and makes revisions to forfeitures on a quarterly basis. Compensation expense is recognized based on the initial valuation and is not subsequently adjusted as a result of the Company’s performance relative to that of the XSD index. Vesting for MSUs is contingent upon both service and market conditions, which is over a four-year period.

There were no MSUs granted for the three months ended December 26, 2015 and December 27, 2014.

The weighted-average fair value of MSUs granted was $29.64 and $15.64 per share for the six months ended December 26, 2015 and December 27, 2014, respectively.

The following table summarizes the number of MSUs outstanding and expected to vest as of December 26, 2015 and their activity during the six months ended December 26, 2015:



	Number of Shares		Weighted Average Remaining Contractual Term (in Years)	Aggregate Intrinsic Value (1)
Balance at June 27, 2015	414,840
Market stock units granted	361,684
Market stock units released	—
Market stock units cancelled	(76,560	)
Balance at December 26, 2015	699,964		3.4	$	26,829,620
Outstanding and expected to vest, December 26, 2015	566,843		3.4	$	21,727,097



(1)	Aggregate intrinsic value for MSUs represents the closing price per share of the Company’s common stock on December 24, 2015, the last business day preceding the fiscal quarter-end, multiplied by the number of MSUs outstanding or expected to vest as of December 26, 2015.

As of December 26, 2015, there was $13.9 million of unrecognized compensation expense related to 0.7 million unvested MSUs, which is expected to be recognized over a weighted average period of approximately 3.4 years.

Employee Stock Purchase Plan

Employees are granted rights to acquire common stock under the Company’s 2008 Employee Stock Purchase Plan (the “ESPP”).

The fair value of ESPP granted to employees has been estimated at the date of grant using the Black-Scholes option valuation model and the following weighted-average assumptions:



	ESPP
	Three Months Ended				Six Months Ended
	December 26, 2015		December 27, 2014		December 26, 2015		December 27, 2014
Expected holding period (in years)	0.5		0.5		0.5		0.5
Risk-free interest rate	0.4	%	0.1	%	0.4	%	0.1	%
Expected stock price volatility	33.1	%	26.4	%	33.1	%	26.4	%
Dividend yield	3.6	%	3.5	%	3.6	%	3.5	%

As of December 26, 2015 and December 27, 2014, there was $7.5 million and $7.7 million, respectively, of unrecognized compensation expense related to the ESPP.

NOTE 7: EARNINGS (LOSS) PER SHARE

Basic earnings (loss) per share are computed using the weighted average number of shares of common stock outstanding during the period. For purposes of computing basic earnings (loss) per share, the weighted average number of outstanding shares of common stock excludes unvested RSUs, including MSUs. Diluted earnings (loss) per share incorporates the incremental shares issuable upon the assumed exercise of stock options, assumed release of unvested RSUs, Performance Shares, including MSUs and assumed issuance of common stock under the employee stock purchase plans using the treasury stock method.

The following table sets forth the computation of basic and diluted earnings (loss) per share:



	Three Months Ended					Six Months Ended
	December 26, 2015		December 27, 2014			December 26, 2015			December 27, 2014
	(in thousands, except per share data)
Numerator for basic earnings (loss) per share and diluted earnings (loss) per share
Net income (loss)	$	67,469	$	(72,034	)	$	(4,674	)	$	27,946

Denominator for basic earnings (loss) per share	285,526		282,992			285,057			283,539
Effect of dilutive securities:
Stock options, ESPP, RSUs, and MSUs	4,995		—			—			5,337
Denominator for diluted earnings (loss) per share	290,521		282,992			285,057			288,876

Earnings (loss) per share
Basic	$	0.24	$	(0.25	)	$	(0.02	)	$	0.10
Diluted	$	0.23	$	(0.25	)	$	(0.02	)	$	0.10

The Company had a net loss for the three months ended December 27, 2014, accordingly all incremental shares totaling 5.8 million shares were determined to be anti-dilutive. The Company had a net loss for the six months ended December 26, 2015, accordingly all incremental shares totaling 5.6 million shares were determined to be anti-dilutive.

Approximately 0.1 million stock options were excluded from the calculation of diluted earnings per share for the three months ended December 26, 2015. Approximately 5.9 million stock options were excluded from the calculation of diluted earnings per share for the six months ended December 27, 2014. These options were excluded because they were determined to be anti-dilutive. However, such options could be dilutive in the future and, under those circumstances, would be included in the calculation of diluted earnings per share.

NOTE 8: SEGMENT INFORMATION

The Company designs, develops, manufactures and markets a broad range of linear and mixed signal integrated circuits.

Prior to the Company's reorganization which occurred in the fourth quarter of fiscal 2015, the Company had three operating segments that the Company aggregated into one reportable segment as the Company concluded the three operating segments shared similar economic and qualitative characteristics. The Company’s reorganization resulted in the consolidation of the management of the Research and Development (“R&D”) and Sales functions under one executive who reports to the Company's Chief Executive Officer (the “CEO”). Previously R&D was managed by three executives who reported to the Company's CEO and Sales was managed by one executive who reported to the Company's CEO. As a result of this reorganization, all of the Company's products are designed through a centralized R&D function, and continue to be manufactured using centralized manufacturing (internal and external), and sold through a centralized sales force and shared wholesale distributors. Through the consolidation of management of the R&D and Sales functions this reorganization is intended to allow for faster investment decisions, improved R&D efficiency, and facilitate stronger collaborations between internal organizations to increase productivity, improve customer satisfaction, and drive revenue growth.

The Company currently has one operating segment. In accordance with ASC No. 280, Segment Reporting (“ASC 280”), the Company considers operating segments to be components of the Company’s business for which separate financial information is available that is evaluated regularly by the Company’s Chief Operating Decision Maker in deciding how to allocate resources and in assessing performance. The Chief Operating Decision Maker for the Company was assessed and determined to be the CEO. The CEO reviews financial information presented on a consolidated basis for purposes of allocating resources and evaluating financial performance. Accordingly, the Company has determined that it has a single operating and reportable segment.

Enterprise-wide information is provided in accordance with ASC 280. Geographical revenue information is based on customers’ ship-to location. Long-lived assets consist of property, plant and equipment. Property, plant and equipment information is based on the physical location of the assets at the end of each fiscal year.

Net revenues by geographic region was as follows:



	Three Months Ended				Six Months Ended
	December 26, 2015		December 27, 2014		December 26, 2015		December 27, 2014
	(in thousands)
United States	$	61,633	$	70,336	$	123,693	$	144,931
China	197,420		242,303		421,657		482,320
Rest of Asia	153,203		155,388		323,137		320,820
Europe	85,951		80,992		177,854		164,957
Rest of World	12,624		17,790		27,000		34,056
	$	510,831	$	566,809	$	1,073,341	$	1,147,084

Net long-lived assets by geographic region were as follows:



	December 26, 2015		June 27, 2015
	(in thousands)
United States	$	455,051	$	783,148
Philippines	181,140		166,405
Thailand	52,175		56,776
Rest of World	82,182		84,410
	$	770,548	$	1,090,739

NOTE 9: COMPREHENSIVE INCOME (LOSS)

The changes in accumulated other comprehensive loss by component and related tax effects in the six months ended December 26, 2015 and December 27, 2014 were as follows:



(in thousands)	Unrealized Gains and Losses on Intercompany Receivables			Unrealized Gains and Losses on Post-Retirement Benefits			Cumulative Translation Adjustment			Unrealized Gains and Losses on Cash Flow Hedges			Unrealized Gains and Losses on Available-For-Sale Securities			Total
June 27, 2015	$	(6,280	)	$	(10,004	)	$	(1,136	)	$	53		$	133		$	(17,234	)
Other comprehensive income (loss) before reclassifications	—			—			—			(941		)	(283		)	(1,224		)
Amounts reclassified out of accumulated other comprehensive loss (income)	—			505			—			415			—			920
Tax effects	—			(161		)	—			170			—			9
Other comprehensive income (loss)	—			344			—			(356		)	(283		)	(295		)
December 26, 2015	$	(6,280	)	$	(9,660	)	$	(1,136	)	$	(303	)	$	(150	)	$	(17,529	)



(in thousands)	Unrealized Gains and Losses on Intercompany Receivables			Unrealized Gains and Losses on Post-Retirement Benefits			Cumulative Translation Adjustment			Unrealized Gains and Losses on Cash Flow Hedges			Unrealized Gains and Losses on Available-For-Sale Securities			Total
June 28, 2014	$	(5,753	)	$	(10,373	)	$	(1,136	)	$	(11	)	$	100		$	(17,173	)
Other comprehensive income (loss) before reclassifications	(116		)	—			—			(1,917		)	(108		)	(2,141		)
Amounts reclassified out of accumulated other comprehensive loss (income)	—			719			—			433			—			1,152
Tax effects	(516		)	(242		)	—			381			—			(377		)
Other comprehensive income (loss)	(632		)	477			—			(1,103		)	(108		)	(1,366		)
December 27, 2014	$	(6,385	)	$	(9,896	)	$	(1,136	)	$	(1,114	)	$	(8	)	$	(18,539	)

NOTE 10: INCOME TAXES

In the three and six months ended December 26, 2015, the Company recorded an income tax provision (benefit) of $12.5 million and $2.4 million, respectively compared to $0.4 million and $(5.1) million in the three and six months ended December 27, 2014, respectively. The Company’s effective tax rate for the three and six months ended December 26, 2015 was 15.6% and (109.9)%, respectively, compared to (0.5)% and (22.5)% for the three and six months ended December 27, 2014, respectively.

The Company’s federal statutory tax rate is 35%. The Company’s effective tax rate for the three months ended December 26, 2015 was lower than the statutory rate primarily because earnings of foreign subsidiaries, generated primarily by the Company's international operations managed in Ireland, were taxed at lower rates and a $2.5 million discrete benefit for fiscal year 2015 research tax credits that were generated by the extension, retroactive to January 1, 2015, of the federal research tax credit by legislation that was signed into law on December 18, 2015, partially offset by stock-based compensation for which no tax benefit is expected.

The Company’s effective tax rate for the six months ended December 26, 2015 was higher than the statutory tax rate primarily because of $3.8 million of discrete interest accruals for unrecognized tax benefits and a $1.0 million discrete charge for prior year unrecognized tax benefits, partially offset by a $2.5 million discrete benefit for fiscal year 2015 research tax credits that were generated by the extension, retroactive to January 1, 2015, of the federal research tax credit by legislation that was signed into law on December 18, 2015.

The Company's effective tax rate for the three months ended December 27, 2014 was higher than the statutory rate primarily because of a $84.1 million discrete goodwill impairment charge that generated no tax benefit and stock-based compensation for which no tax benefit is expected, partially offset by earnings of foreign subsidiaries, generated primarily by the Company's international operations managed in Ireland, taxed at lower tax rates and a $2.9 million discrete benefit for fiscal year 2014 research tax credits that were generated by the extension, retroactive to January 1, 2014, of the federal research tax credit by legislation that was signed into law on December 19, 2014.

The Company’s effective tax rate for the six months ended December 27, 2014 was lower than the statutory tax rate primarily because earnings of foreign subsidiaries, generated primarily by the Company's international operations managed in Ireland, were taxed at lower rates, a $2.9 million discrete benefit for fiscal year 2014 research tax credits that were generated by the extension, retroactive to January 1, 2014, of the federal research tax credit by legislation that was signed into law on December 19, 2014 and a $24.8 million discrete benefit for the favorable settlement of a Singapore tax issue in the first quarter of fiscal year 2015, partially offset by an $84.1 million discrete goodwill impairment charge that generated no tax benefit and stock-based compensation for which no tax benefit is expected.

The Company’s federal corporate income tax returns are audited on a recurring basis by the IRS. In fiscal year 2012 the U.S. Internal Revenue Service commenced an audit of the Company’s federal corporate income tax returns for fiscal years 2009 through 2011, which is still ongoing.

NOTE 11: COMMITMENTS AND CONTINGENCIES

Legal Proceedings

The Company is a party or subject to various legal proceedings and claims, either asserted or unasserted, which arise in the ordinary course of business, including proceedings and claims that relate to intellectual-property matters. While the outcome of these matters cannot be predicted with certainty, we do not believe that the outcome of any of these matters, individually or in the aggregate, will result in losses that are materially in excess of amounts already recognized or reserved, if any.

Indemnification

The Company indemnifies certain customers, distributors, suppliers and subcontractors for attorney fees and damages and costs awarded against such parties in certain circumstances in which the Company’s products are alleged to infringe third party intellectual property rights, including patents, registered trademarks or copyrights. The terms of the Company’s indemnification obligations are generally perpetual from the effective date of the agreement. In certain cases, there are limits on and exceptions to the Company’s potential liability for indemnification relating to intellectual property infringement claims.

Pursuant to the Company’s charter documents and separate written indemnification agreements, the Company has certain indemnification obligations to its current officers, employees and directors, as well as certain former officers and directors.

Product Warranty

The Company generally warrants its products for one year from the date of shipment against defects in materials, workmanship and material non-conformance to the Company’s specifications. The general warranty policy provides for the repair or replacement of defective products or a credit to the customer’s account. In addition, the Company may consider its relationship with the customer when reviewing product warranty claims. In limited circumstances and for strategic customers in certain unique industries and applications, our product warranty may extend for up to five years, and may also include financial responsibility, such as the payment of monetary compensation to reimburse a customer for its financial losses above and beyond repairing or replacing the product or crediting the customer’s account should the product not meet the Company’s specifications and losses and /or damages resulting from the product.

Accruals are based on specifically identified claims and on the estimated, undiscounted cost of incurred-but-not-reported claims. If there is a material increase in the rate of customer claims compared with our historical experience or if the Company’s estimates of probable losses relating to specifically identified warranty exposures require revision, the Company may record a charge against future cost of sales. Product warranty liability is included within the balance sheet captions “Accrued expenses” and “Other liabilities” in the accompanying Condensed Consolidated Balance Sheets.

The changes in the Company’s aggregate product warranty liabilities for the six months ended December 26, 2015 and December 27, 2014 were as follows:



	Six Months Ended
	December 26, 2015			December 27, 2014
Product warranty liability	(in thousands)
Beginning balance	$	14,329		$	21,296
Accruals for warranties	2,247			1,168
Payments	(5,909		)	(7,113		)
Changes in estimate	873			1,380
Ending balance	$	11,540		$	16,731

Less: Current portion	7,240			8,131
Non-current portion	$	4,300		$	8,600

NOTE 12: COMMON STOCK REPURCHASES

In July 2013, the Board of Directors authorized the Company to repurchase up to $1 billion of the Company’s common stock from time to time at the discretion of the Company’s management. This stock repurchase authorization has no expiration date. All prior authorizations by the Company’s Board of Directors for the repurchase of common stock were superseded by this authorization.

During the six months ended December 26, 2015, the Company repurchased approximately 1.8 million shares of its common stock for $62.8 million. As of December 26, 2015, the Company had remaining authorization of $503.9 million for future share repurchases. The number of shares to be repurchased and the timing of such repurchases will be based on several factors, including the price of the Company’s common stock and general market and business conditions.

NOTE 13: GOODWILL AND INTANGIBLE ASSETS

Goodwill

The Company monitors the recoverability of goodwill recorded in connection with acquisitions, by reporting unit, annually, or more often if events or changes in circumstances indicate that the carrying amount may not be recoverable. The Company performed the annual goodwill impairment analysis during the fourth quarter of fiscal year 2015 and concluded that goodwill was not impaired, as the fair value of each reporting unit exceeded its carrying value.

During the quarter ended December 27, 2014, goodwill for the Sensing Solutions reporting unit was determined to be impaired and the Company recorded a charge of $84.1 million. The Sensing Solutions reporting unit develops integrated circuits which are primarily sold in the consumer and automotive end customer markets. The impairment was the result of the Company’s decision within the quarter ended December 27, 2014 to exit certain market offerings that have competitive dynamics which are no longer consistent with the Company’s business objectives.

The Company determined that sufficient indicators of potential impairment existed to require an interim goodwill impairment analysis for the Sensing Solutions reporting unit. The reporting unit’s carrying value exceeded its estimated fair value and, accordingly, a second phase of the goodwill impairment test (“Step 2”) was performed. Under Step 2, the fair value of all Sensing Solution’s assets and liabilities were estimated, including tangible assets and intangible assets (including existing and in-process technology) for the purpose of deriving an estimate of the implied fair value of goodwill. The implied fair value of the goodwill was then compared to the carrying value of the goodwill to determine the amount of the impairment.

The Company estimated the fair value of the Sensing Solutions reporting unit using a weighting of fair values derived equally from the income and market approach. Under the income approach, the Company calculates the fair value of a reporting unit based on the present value of estimated future cash flows. Cash flow projections are based on management’s estimates of revenue growth rates and operating margins, taking into consideration industry and market conditions. The discount rate used is based on the weighted-average cost of capital adjusted for the relevant risk associated with business-specific characteristics and the uncertainty related to the business’s ability to execute on the projected cash flows. The market approach estimates fair value based on market multiples of revenue and earnings derived from comparable publicly-traded companies with similar operating and investment characteristics as the reporting unit.

Prior to completing the goodwill impairment test, the Company tested the recoverability of the Sensing Solutions long-lived assets (other than goodwill) and concluded that existing Property, plant and equipment, net was impaired by $45.2 million and IPR&D was impaired by $8.9 million.

No indicators or instances of impairment were identified in the six months ended December 26, 2015.

During the three months ended December 26, 2015, $21.0 million of goodwill was reclassified as held for sale. For details, please refer to Note 3: "Balance sheet components" and Note 14: “Impairment of long-lived assets”.

Intangible Assets

The useful lives of amortizable intangible assets are as follows:



Asset		Life
Intellectual property		1-10 years
Customer relationships		4-10 years
Trade name		3-4 years
Patents		5 years

Intangible assets consisted of the following:



	December 26, 2015						June 27, 2015
	Original Cost		Accumulated Amortization		Net		Original Cost		Accumulated Amortization		Net
	(in thousands)
Intellectual property	$	347,262	$	234,639	$	112,623	$	435,962	$	276,175	$	159,787
Customer relationships	96,830		69,925		26,905		120,230		82,774		37,456
Trade name	8,500		5,686		2,814		8,500		4,886		3,614
Patents	2,500		1,167		1,333		2,500		907		1,593
Total amortizable purchased intangible assets	455,092		311,417		143,675		567,192		364,742		202,450
IPR&D	59,202		—		59,202		59,202		—		59,202
Total purchased intangible assets	$	514,294	$	311,417	$	202,877	$	626,394	$	364,742	$	261,652

During the three months ended December 26, 2015, $20.3 million of purchased intangible assets, net, was reclassified as held for sale. For details, please refer to Note 3: "Balance sheet components" and Note 14: “Impairment of long-lived assets”.

The following table presents the amortization expense of intangible assets and its presentation in the Condensed Consolidated Statements of Income:



	Three Months Ended				Six Months Ended
	December 26, 2015		December 27, 2014		December 26, 2015		December 27, 2014
	(in thousands)
Cost of goods sold	$	14,734	$	18,750	$	31,372	$	37,500
Intangible asset amortization	3,538		4,155		7,129		8,482
Total intangible asset amortization expenses	$	18,272	$	22,905	$	38,501	$	45,982

The following table represents the estimated future amortization expense of intangible assets as of December 26, 2015:



Fiscal Year	Amount
	(in thousands)
Remaining six months of 2016	$	28,734
2017	49,091
2018	41,563
2019	13,278
2020	3,358
2021	2,888
Thereafter	4,763
Total intangible assets	$	143,675

NOTE 14: IMPAIRMENT OF LONG-LIVED ASSETS

Fiscal year 2016:

During the first quarter of fiscal year 2016, the Company recorded a $157.7 million impairment of long-lived assets associated with the Company's wafer manufacturing facility in San Antonio, Texas which was classified as held for sale and written down to fair value, less cost to sell. The Company reached its conclusion regarding the asset impairment after conducting an evaluation

of assets' fair values. The fair value of the land, buildings and equipment was determined after consideration of expected discounted future cash flows attributable to the assets and outside appraisals. The Company signed an agreement with TJ Texas, Inc., a wholly-owned subsidiary of Tower Semiconductor Ltd., for the sale of the semiconductor wafer fabrication facility in San Antonio, Texas on November 18, 2015.

In addition, the San Jose wafer fabrication facility was classified as held for sale during the first quarter of fiscal year 2016, but no impairment charge was recorded as the carrying value of the associated assets approximated the fair value, less cost to sell. The fair value of the land, buildings and equipment was determined after consideration of outside appraisals, quoted market prices of similar equipment and offers received. The Company completed the sale of this facility in the second quarter of fiscal year 2016 for approximately $39.0 million resulting in a gain of $3.8 million.

During the second quarter of fiscal year 2016, the Company classified certain business units, including associated tangible, intangible assets and goodwill, as held for sale but no impairment charge was recorded as the carrying value of each of the business units' associated assets approximates or is less than the fair value, less cost to sell. The fair values of the assets were determined after consideration of offers received. The Company plans on completing these sales during fiscal year 2016.

Fiscal year 2015:

During the three and six months ended December 27, 2014, the Company recorded $50.7 million and $61.0 million, respectively, in impairment of long-lived assets in the Company’s Condensed Consolidated Statements of Income.

The impairment was primarily related to the write down of equipment relating to the Sensing Solutions reporting unit of $45.2 million. The Company reached its conclusion regarding the asset impairment after concluding that the undiscounted cash flows fell below the net book value of the net assets of the Sensing Solutions reporting unit (the asset group). As a result, the Company reduced the assets to their fair value after conducting an evaluation of each asset’s alternative use, the condition of the asset and the current market pricing and demand.

The impairment was also related to used fabrication tools identified by the Company as obsolete in the three months ended December 27, 2014 due to the transition to newer technologies. The Company reached its conclusion regarding the asset impairment after conducting an evaluation of alternative use, the condition of the assets and current market demand.

NOTE 15: RESTRUCTURING ACTIVITIES

Fiscal year 2016:

Summary of Restructuring Plans

The Company has accruals for severance and restructuring payments as well as expected losses relating to lease terminations.

The Company’s restructuring activities in the six months ended December 26, 2015 were as follows:



	Balance, June 27, 2015		Six Months Ended December 26, 2015								Balance, December 26, 2015		As of December 26, 2015
	Balance, June 27, 2015		Charges		Cash Payments			Change in Estimates			Balance, December 26, 2015		Costs Incurred to Date (4)		Expected Costs to be Incurred
	(in thousands)
San Jose Fab Shutdown
Severance (1)	$	6,725	$	973	$	(5,104	)	$	(553	)	$	2,041	$	7,145	$	—
Accelerated depreciation (2)	—		41,600		—			—			41,600		93,094		—
Total San Jose Fab Shutdown	6,725		42,573		(5,104		)	(553		)	43,641		100,239		—

Other Plans
Severance (1)	11,496		15,940		(16,110		)	586			11,912		46,225		467
Dallas manufacturing facility accelerated depreciation (2)	$	—	$	4,064	$	—		$	—		$	4,064	$	4,064	$	12,191
Lease termination losses and other (3)	3,754		1,743		(253		)	(1,225		)	4,019		8,876		—
Total other plans	15,250		21,747		(16,363		)	(639		)	19,995		59,165		12,658
Total restructuring plans	$	21,975	$	64,320	$	(21,467	)	$	(1,192	)	$	63,636	$	159,404	$	12,658

In Balance Sheets:
Accrued salary and related expenses	$	18,221									$	13,953
Accrued expenses	$	2,004									$	2,410
Other liabilities	$	1,750									$	1,609

(1) Charges and change in estimates are included in Severance and restructuring expenses in the accompanying Condensed Consolidated Statements of Income.

(2) Charges and change in estimates are included in Cost of goods sold in the accompanying Condensed Consolidated Statements of Income.

(3) Charges and change in estimates are included in Severance and restructuring expenses and Other operating expenses (income), net in the accompanying Condensed Consolidated Statements of Income.

(4) Costs incurred to date presents the cumulative costs recorded in fiscal year 2015 and 2016 for the above named restructuring activities.

San Jose Fab Shutdown

In October 2014, the Company initiated a plan to shut down its San Jose wafer fabrication facility. The Company reached the decision that it was not economically feasible to maintain this facility, which is used primarily for fab process development and low volume manufacturing, as the Company intended to utilize other resources to complete such activities in the future. This plan included cash charges related to employee severance and non-cash charges related to accelerated depreciation. This plan has been completed, and the shutdown took place in the second quarter of fiscal year 2016.

During the three and six months ended December 26, 2015, the Company recorded accelerated depreciation charges of $0 and $41.6 million, respectively, in “Cost of goods sold” and $0 and $0.4 million, respectively, in “Severance and restructuring expenses” in the Condensed Consolidated Statements of Income. The sale of the San Jose wafer fabrication facility took place during the second quarter of fiscal year 2016.

Other Plans

During the three and six months ended December 26, 2015, the Company recorded $10.7 million and $17.0 million, respectively, in “Severance and restructuring expenses” in the Condensed Consolidated Statements of Income related to various restructuring plans designed to reduce costs. These charges were associated with continued reorganization of certain business units and functions and the planned closure the Dallas wafer level packaging (“WLP”) manufacturing facilities. Multiple job classifications and locations were impacted by these activities.

As the Company plans to close its WLP manufacturing facility in Dallas, Texas in fiscal year 2017, the Company recorded accelerated depreciation charges of $2.0 million and $4.1 million during the three and six months ended December 26, 2015, respectively.

The Company also accrues for expected losses relating to lease terminations as a result of plans to consolidate office space. The need for consolidation resulted from acquisition and relocation activities.

Fiscal year 2015:

Severance and restructuring expenses were $13.6 million and $15.0 million for the three and six months ended December 27, 2014.

Change in estimate:

Due to the above mentioned restructuring activities, the Company recorded accelerated depreciation resulting from the change in estimated useful lives of certain long lived assets included in restructuring plans. In all periods that accelerated depreciation expense was recorded, this resulted in additional expense and therefore impacted operating income (loss), net income (loss) and earnings per share as presented in the table below.



	Three Months Ended						Six Months Ended
	December 26, 2015			December 27, 2014			December 26, 2015			December 27 2014
	(in thousands, except per share data)
Operating income (loss), as reported	$	89,533		$	(64,076	)	$	13,768		$	36,882
Operating income (loss), excluding accelerated depreciation expense	91,565			(55,181		)	59,432			45,777
Effect of change in estimate	$	(2,032	)	$	(8,895	)	$	(45,664	)	$	(8,895	)

Net income (loss), as reported	$	67,469		$	(72,034	)	$	(4,674	)	$	27,946
Net income (loss), excluding accelerated depreciation expense	73,119			(62,278		)	37,705			37,702
Effect of change in estimate	$	(5,650	)	$	(9,756	)	$	(42,379	)	$	(9,756	)

Basic earnings (loss) per share, as reported	$	0.24		$	(0.25	)	$	(0.02	)	$	0.10
Diluted earnings (loss) per share, as reported	$	0.23		$	(0.25	)	$	(0.02	)	$	0.10

Basic earnings (loss) per share, excluding accelerated depreciation expense	$	0.26		$	(0.22	)	$	0.13		$	0.13
Diluted earnings (loss) per share, excluding accelerated depreciation expense	$	0.25		$	(0.22	)	$	0.13		$	0.13

Effect of change in estimate - basic earnings (loss) per share	$	(0.02	)	$	(0.03	)	$	(0.15	)	$	(0.03	)
Effect of change in estimate - diluted earnings (loss) per share	$	(0.02	)	$	(0.03	)	$	(0.15	)	$	(0.03	)

NOTE 16: SUBSEQUENT EVENT

On December 30, 2015, the Company entered into an agreement to sell its energy metering business to Silergy Corporation, an analog semiconductor company with operations in the U.S. and Asia, for approximately $105.0 million. The Company expects to close the transaction during the third quarter of fiscal 2016 subject to the satisfaction of customary closing conditions.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Maxim Integrated Products, Inc. (“Maxim Integrated” or the “Company” and also referred to as “we,” “our” or “us”) disclaims any duty to and undertakes no obligation to update any forward-looking statement, whether as a result of new information relating to existing conditions, future events or otherwise or to release publicly the results of any future revisions it may make to forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as required by federal securities laws. Readers are cautioned not to place undue reliance on such statements, which speak only as of the date of this Quarterly Report on Form 10-Q. Readers should carefully review future reports and documents that the Company files with or furnishes to the SEC from time to time, such as its Annual Reports on Form 10-K, its Quarterly Reports on Form 10-Q and any Current Reports on Form 8-K.

Overview of Business

Maxim Integrated is incorporated in the state of Delaware. Maxim Integrated designs, develops, manufactures and markets a broad range of linear and mixed-signal integrated circuits, commonly referred to as analog circuits, for a large number of geographically diverse customers. The Company also provides a range of high-frequency process technologies and capabilities that can be used in custom designs. The analog market is fragmented and characterized by many diverse applications, a great number of product variations and, with respect to many circuit types, relatively long product life cycles. The Company is a global company with wafer manufacturing facilities in the U.S., testing facilities in the Philippines and Thailand and sales and circuit design offices throughout the world. The major end-markets in which the Company’s products are sold are the Automotive, Communications and Data Center, Computing, Consumer and Industrial markets.

In October 2014, the Company initiated a plan to shut down its San Jose wafer fabrication facility. The Company has incurred to date a total of $100.2 million of accelerated depreciation and severance charges related to this plan which was completed in the second quarter of fiscal year 2016.

During fiscal year 2015, we commenced activities to close down the operations in our Batangas, Philippines manufacturing site, and the close was completed in the second quarter of fiscal year 2016. All related capacity and manufacturing requirements were transferred to our other existing manufacturing locations or alternatively to our third party subcontractors.

During fiscal year 2015, we also commenced activities to close down the operations in our Hillsboro, Oregon testing site which will be completed in fiscal year 2016.

Additionally, we announced in July 2015 the planned transfer and sale of our wafer manufacturing facility in San Antonio, Texas to a foundry partner in fiscal year 2016. During the first quarter of fiscal 2016, this facility was classified as held for sale and written down to fair value, less cost to sell, resulting in an impairment charge of $157.7 million.

Also, we announced in July 2015 that we intend to close our wafer level packaging manufacturing facility in Dallas, Texas in fiscal year 2017. This plan includes the sale of our Dallas campus as well as the leasing of new office space for remaining design, administration and manufacturing functions.

As a result of these above mentioned actions, we expect to incur additional severance and restructuring expenses throughout our fiscal year 2016.

CRITICAL ACCOUNTING POLICIES

The methods, estimates and judgments we use in applying our most critical accounting policies have a significant impact on the results we report in our financial statements. The Securities and Exchange Commission (“SEC”) has defined the most critical accounting policies as the ones that are most important to the presentation of our financial condition and results of operations, and that require us to make our most difficult and subjective accounting judgments, often as a result of the need to make estimates of matters that are inherently uncertain. Based on this definition, our most critical accounting policies include revenue recognition, which impacts the recording of net revenues; valuation of inventories, which impacts costs of goods sold and gross margins; the assessment of recoverability of long-lived assets, which impacts impairment of long-lived assets; assessment of recoverability of intangible assets and goodwill, which impacts impairment of goodwill and intangible assets; accounting for stock-based compensation, which impacts cost of goods sold, gross margins and operating expenses; accounting for income taxes, which impacts the income tax provision; and assessment of litigation and contingencies, which impacts charges recorded in cost of goods sold, selling, general and administrative expenses and income taxes. These policies and the estimates and judgments involved are discussed further below. We have other significant accounting policies that either do not generally require estimates and judgments that are as difficult or subjective, or it is less likely that such accounting policies would have a material impact on our reported results of operations for a given period.

There have been no material changes during the six months ended December 26, 2015 to the items that we disclosed as our critical accounting policies and estimates in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the fiscal year ended June 27, 2015, except for the adoption of ASU No. 2015-17, Balance Sheet Classification of Deferred Taxes. Please refer to Part I, Item 1, Note 2: "Recently Issued Accounting Pronouncements" to the Condensed Consolidated Financial Statements for additional details of the adoption and impact of this standard update.

RESULTS OF OPERATIONS

The following table sets forth certain Condensed Consolidated Statements of Income data expressed as a percentage of net revenues for the periods indicated:



	Three Months Ended				Six Months Ended
	December 26, 2015		December 27, 2014		December 26, 2015		December 27, 2014

Net revenues	100.0	%	100.0	%	100.0	%	100.0	%
Cost of goods sold	42.8	%	44.6	%	46.1	%	43.1	%
Gross margin	57.2	%	55.4	%	53.9	%	56.9	%
Operating expenses:
Research and development	22.1	%	24.0	%	21.8	%	24.1	%
Selling, general and administrative	14.4	%	14.1	%	13.6	%	13.9	%
Intangible asset amortization	0.7	%	0.7	%	0.7	%	0.7	%
Impairment of long-lived assets	0.4	%	9.0	%	14.9	%	5.3	%
Impairment of goodwill and intangible assets	—	%	16.4	%	—	%	8.1	%
Severance and restructuring expenses	2.1	%	2.4	%	1.7	%	1.3	%
Other operating expenses (income), net	—	%	0.2	%	—	%	0.2	%
Total operating expenses	39.7	%	66.8	%	52.7	%	53.6	%
Operating income	17.5	%	(11.4	)%	1.2	%	3.3	%
Interest and other income (expense), net	(1.9	)%	(1.3	)%	(1.5	)%	(1.2	)%
Income before provision for income taxes	15.6	%	(12.7	)%	(0.3	)%	2.1	%
Income tax provision (benefit)	2.4	%	0.1	%	0.2	%	(0.4	)%
Net income (loss)	13.2	%	(12.8	)%	(0.5	)%	2.5	%

The following table shows stock-based compensation included in the components of the Condensed Consolidated Statements of Income reported above as a percentage of net revenues for the periods indicated:



	Three Months Ended				Six Months Ended
	December 26, 2015		December 27, 2014		December 26, 2015		December 27, 2014
Cost of goods sold	0.6	%	0.5	%	0.5	%	0.5	%
Research and development	1.8	%	2.0	%	1.6	%	2.1	%
Selling, general and administrative	1.3	%	1.2	%	1.2	%	1.2	%
	3.7	%	3.7	%	3.3	%	3.8	%

Net Revenues

Net revenues were $510.8 million and $566.8 million for the three months ended December 26, 2015 and December 27, 2014, respectively, a decrease of 9.9%. Revenue from consumer products was down 23%, primarily driven by lower demand for smartphones. Revenue from communications and data center products was down 18%, mainly due to lower demand for server, basestation and data storage products. These decreases were partially offset by a 34% increase in net revenues in automotive products, primarily driven by infotainment.

Net revenues were $1,073.3 million and $1,147.1 million for the six months ended December 26, 2015 and December 27, 2014, respectively, a decrease of 6.4%. Revenue from communications and data center was down 21%, mainly due to lower demand for server, basestation and data storage products. Revenue from consumer products was down 10%, primarily driven by lower demand for smartphones. This decrease was partially offset by an increase in automotive net revenues of 37%, primarily driven by infotainment.

During the three months ended December 26, 2015 and December 27, 2014, approximately 88% and 88% of net revenues, respectively, were derived from customers outside of the United States. While more than 95% of these sales are denominated in U.S. Dollars, we enter into foreign currency forward contracts to mitigate our risks on firm commitments and net monetary assets and liabilities denominated in foreign currencies. The impact of changes in foreign exchange rates on our revenue and results of operations for the three and six months ended December 26, 2015 and December 27, 2014 was immaterial.

Gross Margin

Our gross margin percentages were 57.2% and 55.4% for the three months ended December 26, 2015 and December 27, 2014, respectively. Our gross margin increased by 1.8%, primarily from a $6.9 million decrease in accelerated depreciation (1.2% increase to gross margin) relating primarily to the San Jose wafer fabrication facility shut down, which began in the second quarter of 2015 and was completed in the second quarter of fiscal year 2016.

Our gross margin percentages were 53.9% and 56.9% for the six months ended December 26, 2015 and December 27, 2014, respectively. Our gross margin decreased by 3.0%, primarily from a $36.8 million increase in accelerated depreciation (3.5% decrease to gross margin) relating primarily to the San Jose wafer fabrication facility shut down.

The below table presents the impact of accelerated depreciation expense on gross margin for all periods presented.



	Three Months Ended						Six Months Ended
	December 26, 2015			December 27, 2014			December 26, 2015			December 27 2014
	(in thousands, except per share data)
Gross margin, as reported	$	292,169		$	314,077		$	578,520		$	652,898
Accelerated depreciation expense	2,032			8,895			45,664			8,895
Gross margin, without accelerated depreciation expense	$	294,201		$	322,972		$	624,184		$	661,793

Gross margin %, as reported	57.2		%	55.4		%	53.9		%	56.9		%
Gross margin %, without accelerated depreciation expense	57.6		%	57.0		%	58.2		%	57.7		%
Impact percentage	(0.4		)%	(1.6		)%	(4.3		)%	(0.8		)%

Research and Development

Research and development expenses were $113.1 million and $135.9 million for the three months ended December 26, 2015 and December 27, 2014, respectively, which represented 22.1% and 24.0% of net revenues for each respective period. The $22.8 million decrease was primarily attributable to a decrease in salaries and related expenses of $16.2 million as a result of headcount reductions primarily due to restructuring programs and spending control efforts.

Research and development expenses were $234.5 million and $276.3 million for the six months ended December 26, 2015 and December 27, 2014, respectively, which represented 21.8% and 24.1% of net revenues for each respective period. The $41.8 million decrease was primarily attributable to a decrease in salaries and related expenses of $31.7 million as a result of headcount reductions primarily due to restructuring programs and spending control efforts.

Selling, General and Administrative

Selling, general and administrative expenses were $73.6 million and $79.8 million for the three months ended December 26, 2015 and December 27, 2014, respectively, which represented 14.4% and 14.1% of net revenues for each respective period. The $6.2 million decrease was primarily attributable to spending control efforts and a decrease in salaries and related expenses primarily resulting from headcount reductions.

Selling, general and administrative expenses were $145.6 million and $159.8 million for the six months ended December 26, 2015 and December 27, 2014, respectively, which represented 13.6% and 13.9% of net revenues for each respective period. The $14.2

million decrease was primarily attributable to spending control efforts and a decrease in salaries and related expenses primarily resulting from headcount reductions.

Impairment of Long-Lived Assets

Impairment of long-lived assets were $2.0 million and $50.7 million for the three months ended December 26, 2015 and December 27, 2014, respectively, which represented 0.4% and 9.0% of net revenues for each respective period. The $48.7 million decrease was primarily due to equipment impairment associated with the Sensing Solutions Reporting unit during the three months ended December 27, 2014.

Impairment of long-lived assets were $159.6 million and $61.0 million for the six months ended December 26, 2015 and December 27, 2014, respectively, which represented 14.9% and 5.3% of net revenues for each respective period. The $98.6 million increase was primarily due to classification of our wafer manufacturing facility in San Antonio, Texas as held for sale in the first quarter of fiscal year 2016 and therefore written down to fair value, less cost to sell.

Severance and Restructuring Expenses

Severance and restructuring expenses were $10.7 million and $13.6 million for the three months ended December 26, 2015 and December 27, 2014, respectively, which represented 2.1% and 2.4% of net revenues for each respective period. The $2.9 million decrease was primarily due to the timing of restructuring cost associated with the major reorganization of the Company's business units and shut down of San Jose wafer fabrication facility.

Severance and restructuring expenses were $17.8 million and $15.0 million for the six months ended December 26, 2015 and December 27, 2014, respectively, which represented 1.7% and 1.3% of net revenues for each respective period. The $2.8 million increase was primarily due to restructuring activities associated with the major reorganization of the Company's business units and planned closure of our wafer level packaging manufacturing facility in Dallas.

Other Operating Expenses (Income), net

Other operating expenses (income), net were $(0.2) million and $0.9 million during the three months ended December 26, 2015 and December 27, 2014, respectively, which represented 0.0% and 0.2% of net revenues for each respective period. This net decrease in other operating expenses of $1.1 million was primarily driven by the $3.8 million gain on the asset sale of our San Jose wafer fabrication facility.

Other operating expenses (income), net were $0.1 million and $2.5 million during the six months ended December 26, 2015 and December 27, 2014, respectively, which represented 0.0% and 0.2% of net revenues for each respective period. This net decrease in other operating expenses of $2.4 million was primarily driven by the gain on the asset sale of our San Jose wafer fabrication facility.

Interest and Other Income (Expense), net

Interest and other income (expense), net were $(9.6) million and $(7.6) million for the three months ended December 26, 2015 and December 27, 2014, respectively, which represented 1.9% and 1.3% of net revenues for each respective period. The change in interest and other expense of $(2.0) million was primarily driven by the impact from foreign currency exchange rates movements.

Interest and other income (expense), net were $(16.0) million and $(14.1) million for the six months ended December 26, 2015 and December 27, 2014, respectively, which represented 1.5% and 1.2% of net revenues for each respective period. The change in interest and other expense of $(1.9) million was primarily driven by the impact from foreign currency exchange rates movements.

Provision for Income Taxes

In the three and six months ended December 26, 2015,the Company recorded an income tax provision (benefit) of $12.5 million and $2.4 million, respectively, compared to $0.4 million and $(5.1) million in the three and six months ended December 27, 2014, respectively. The Company's effective tax rate for the three and six months ended December 26, 2015 was 15.6% and (109.9)%, respectively, compared to (0.5)% and (22.5)% for the three and six months ended December 27, 2014, respectively.

credits that were generated by the extension, retroactive to January 1, 2015, of the federal research tax credit by legislation that was signed into law on December 18, 2015, partially offset by stock-based compensation for which no tax benefit is expected.

The Company's effective tax rate for the three months ended December 27, 2014 was higher than the statutory rate primarily because of a $84.1 million discrete goodwill impairment charge that generated no tax benefit and stock-based compensation for which no tax benefit is expected, partially offset by earnings of foreign subsidiaries, generated primarily by our international operations managed in Ireland, taxed at lower tax rates and a $2.9 million discrete benefit for fiscal year 2014 research tax credits that were generated by the extension, retroactive to January 1, 2014, of the federal research tax credit by legislation that was signed into law on December 19, 2014.

The Company’s effective tax rate for the six months ended December 27, 2014 was lower than the statutory tax rate primarily because earnings of foreign subsidiaries, generated primarily by our international operations managed in Ireland, were taxed at lower rates, a $2.9 million discrete benefit for fiscal year 2014 research tax credits that were generated by the extension, retroactive to January 1, 2014, of the federal research tax credit by legislation that was signed into law on December 19, 2014 and a $24.8 million discrete benefit for the favorable settlement of a Singapore tax issue in the first quarter of fiscal year 2015, partially offset by an $84.1 million discrete goodwill impairment charge that generated no tax benefit and stock-based compensation for which no tax benefit is expected.

BACKLOG

At December 26, 2015 and September 26, 2015, our current quarter backlog was approximately $328.8 million and $329.4 million, respectively. We include in backlog orders with customer request dates within the next three months. As is customary in the semiconductor industry, these orders may be canceled in most cases without penalty to customers. In addition, backlog includes orders from domestic distributors for which revenues are not recognized until the products are sold by the distributors. Accordingly, we believe that our backlog is not a reliable measure of future revenues. All backlog numbers have been adjusted for estimated future distribution ship and debit pricing adjustments.

FINANCIAL CONDITION, LIQUIDITY AND CAPITAL RESOURCES

Financial Condition

Cash flows were as follows:



	Six Months Ended
	December 26, 2015			December 27, 2014
	(in thousands)
Net cash provided by (used in) operating activities	$	299,828		$	289,852
Net cash provided by (used in) investing activities	(33,751		)	(50,734		)
Net cash provided by (used in) financing activities	(168,524		)	(255,720		)
Net increase (decrease) in cash and cash equivalents	$	97,553		$	(16,602	)

Operating activities

Cash provided by operating activities is net income adjusted for certain non-cash items and changes in certain assets and liabilities.

Cash provided by operating activities was $299.8 million in the six months ended December 26, 2015, an increase of $10.0 million compared with the six months ended December 27, 2014. This increase was primarily driven by a decrease in inventory of $30.7 million due to actions to keep inventory balances in line with current revenue levels, a decrease in other current assets of $27.8 million due to the timing of payments of prepaid and other current assets, and a decrease in accounts receivable of $10.3 million driven by the timing of collections from customers. These were offset by a decrease in accounts payable and other accrued liabilities

of $29.3 million related to the timing of payments. The increase from the change in assets and liabilities, net, was partially offset by the decrease in net income of $32.6 million.

Investing activities

Investing cash flows consist primarily of capital expenditures, net investment purchases and maturities and acquisitions.

Cash used in investing activities decreased by $17.0 million for the six months ended December 26, 2015 compared with the six months ended December 27, 2014. The decrease was due primarily to $25.6 million of additional proceeds from the sale of property, plant and equipment, the majority of which was from the sale of our San Jose wafer manufacturing facility for $39.0 million, and $20.9 million of reduction in capital expenditures relating to property, plant and equipment due to the Company's goal to reduce capital expenditure to a lower percentage of net revenue. This decrease was offset by a $24.9 million increase relating to additional purchases of U.S. treasury securities.

Financing activities

Financing cash flows consist primarily of debt issuance, repurchases of common stock and payment of dividends to stockholders.

Net cash used in financing activities decreased by approximately $87.2 million for the six months ended December 26, 2015 compared to the six months ended December 27, 2014. The decrease was primarily due to $59.5 million in lower repurchases of our common stock and $39.4 million in higher proceeds received from the exercise of stock options. This decrease was offset primarily due to an increase of $12.2 million dividend payments.

Liquidity and Capital Resources

Debt Levels

On November 21, 2013, the Company completed a public offering of $500 million aggregate principal amount of the Company’s 2.5% senior unsecured and unsubordinated notes due on November 15, 2018.

On March 18, 2013, the Company completed a public offering of $500 million aggregate principal amount of the Company’s 3.375% senior unsecured and unsubordinated notes due on March 15, 2023.

The estimated fair value of outstanding debt is at $995 million and $992 million as of December 26, 2015 and June 27, 2015, respectively.

The Company believes that its existing sources of liquidity and cash expected to be generated from future operations, together with existing and available borrowing resources if needed, will be sufficient to fund operations, capital expenditures, research and development efforts, dividend payments, common stock repurchases, debt repayments and acquisitions for at least the next twelve months.

Off-Balance-Sheet Arrangements

As of December 26, 2015, the Company did not have any material off-balance-sheet arrangements, as defined in Item 303(a)(4)(ii) of SEC Regulation S-K.

ITEM 3: QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

The Company’s market risk has not changed materially from the interest rate and foreign currency risks disclosed in Item 7A of the Company’s Annual Report on Form 10-K for the fiscal year ended June 27, 2015.

The impact of inflation and changing prices on the Company’s net revenues and on operating income during the three and six months ended December 26, 2015 and December 27, 2014 was not material.

ITEM 4: CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our chief executive officer (“CEO”) and our chief financial officer (“CFO”), evaluated the effectiveness of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 (the “Exchange Act”) as of December 26, 2015. Our management, including the CEO and the CFO, has concluded that the Company’s disclosure controls and procedures were effective as of December 26, 2015. The purpose of these controls and procedures is to ensure that information required to be disclosed in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules, and that such information is accumulated and communicated to our management, including our CEO and our CFO, to allow timely decisions regarding required disclosures.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting during the quarter ended December 26, 2015 that have materially affected or are reasonably likely to materially affect, our internal control over financial reporting.

Inherent Limitations on the Effectiveness of Internal Controls

A system of internal control over financial reporting is intended to provide reasonable assurance regarding the reliability of financial reporting and the preparation of consolidated financial statements in accordance with GAAP and no control system, no matter how well designed and operated, can provide absolute assurance. The design of any control system is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Because of its inherent limitations, internal control over financial reporting may not prevent or detect financial statement errors and misstatements. Also, projection of any evaluation of effectiveness to future periods is subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate.

PART II. OTHER INFORMATION

ITEM 1: LEGAL PROCEEDINGS

The information set forth above under Part I, Item 1, Note 11 “Commitment and Contingencies” to the Condensed Consolidated Financial Statements is incorporated herein by reference.

ITEM 1A: RISK FACTORS

A description of risks associated with our business, financial condition and results of our operations is set forth in Item 1A - Risk Factors of our Annual Report on Form 10-K for the fiscal year ended June 27, 2015, which is incorporated herein by reference.

ITEM 2: UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

On July 25, 2013, the Board of Directors authorized the Company to repurchase up to $1 billion of the Company’s common stock from time to time at the discretion of the Company’s management. This stock repurchase authorization has no expiration date. All prior authorizations by the Company’s Board of Directors for the repurchase of common stock were superseded by this authorization.

The following table summarizes the activity related to stock repurchases for the three months ended December 26, 2015:



	Issuer Repurchases of Equity Securities
	(in thousands, except per share amounts)
	Total Number of Shares Purchased	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs
Sep. 27, 2015 - Oct. 24, 2015	331	$	34.06	331	$	515,827
Oct. 25, 2015 - Nov. 21, 2015	120	39.58		120	511,066
Nov. 22, 2015 - Dec. 26, 2015	187	38.19		187	503,934
Total for the quarter	638	$	36.31	638	$	503,934

In the fiscal quarter ended December 26, 2015, the Company repurchased approximately 0.6 million shares of its common stock for approximately $23.2 million. As of December 26, 2015, the Company had remaining authorization of $503.9 million for future share repurchases. The number of shares to be repurchased and the timing of such repurchases will be based on several factors, including the price of the Company’s common stock and general market and business conditions.

ITEM 3: DEFAULTS UPON SENIOR SECURITIES

Not applicable.

ITEM 4: MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5: OTHER INFORMATION

None

ITEM 6: EXHIBITS

(a) Exhibits



3.1	Amended and Restated Bylaws
3.2	Certificate of Amendment of Restated Certificate of Incorporation (1)
10.1	Supply Agreement between the Company and TowerJazz Texas, Inc. (formerly known as TJ Texas, Inc.), a Delaware corporation and indirect wholly-owned subsidiary of Tower Semiconductor Ltd., an Israeli corporation, executed as of November 18, 2015 (2)
31.1	Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act
31.2	Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act
32.1	Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350 (3)
32.2	Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350 (3)
101.INS	XBRL Instance Document
101.SCH	XBRL Taxonomy Extension Schema Document
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	XBRL Taxonomy Extension Label Linkbase Document
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document



(1) Incorporated by reference to the Company’s Current Report on Form 8-K filed with the SEC on November 17, 2015.

(2) Portions of this exhibit (indicated by bracketed asterisks) have been omitted, pursuant to request for confidential treatment filed with the SEC.

(3) This exhibit is being furnished rather than filed and shall not be deemed incorporated by reference into any filing, in accordance with Item 601 of Regulation S-K.

Attached as Exhibit 101 to this report are the following formatted in XBRL (Extensible Business Reporting Language): (i) Condensed Consolidated Statements of Income for the three and six months ended December 26, 2015, (ii) Condensed Consolidated Balance Sheets at December 26, 2015 and June 27, 2015, (iii) Condensed Consolidated Statement of Comprehensive Income for the three and six months ended December 26, 2015, (iv) Condensed Consolidated Statements of Cash Flows for the six months ended December 26, 2015 and (v) Notes to Condensed Consolidated Financial Statements.

In accordance with Rule 406T of Regulation S-T, the XBRL-related information in Exhibit 101 to this Quarterly Report on Form 10-Q is deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act, is deemed not filed for purposes of Section 18 of the Exchange Act, and otherwise is not subject to liability under these sections.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the report has been signed below by the following person on behalf of the registrant and in the capacity indicated.



January 22, 2016		MAXIM INTEGRATED PRODUCTS, INC.

		By:/s/ David A. Caron

		David A. Caron
		Vice President and Chief Accounting Officer
		(Chief Accounting Officer and Duly Authorized Officer)